glp-1 purpose Agonists: Using Semaglutide, Tirzepatide, and Orforglipron for Weight Loss and Obesity Indications for GLP-1/GIP RA Summary

No, each medication has a different potency and a specific administration schedule

For patients, the practical takeaway is straightforward: if your inflammation is closely tied to insulin resistance, central weight gain, fatty liver, or metabolic syndrome, a GLP-1 medication may help

REIMAGINE 3 was a 40-week efficacy and safety phase 3 trial of CagriSema 2.4 mg/2.4 mg and 1 mg/1 mg once-weekly versus placebo in 274 adults with type 2 diabetes as add-on to once-daily basal insulin with or without metformin

While taking these medications, patients often do not report feeling hungry or feel as if they are dieting

Clinical Nutrition ESPEN , 37 , 9-23

Most patients find these symptoms diminish as their body adapts to the medicine, often during the titration period